drugset / Trial / NCT02183259
Bioavailability, Pharmacokinetics and Safety of ESR 1150 CL in Healthy Adult Male Volunteers
Non-randomizedCrossoverOpen-labelTreatment
Summary
To investigate the bioavailability of ESR 1150 CL by the time course determination of plasma concentration (pharmacokinetics) of no-transformed ESR 1150 after single administration to healthy adult male volunteers. Secondary objective is to investigate the safety of ESR 1150 CL.
Timeline
- Start
- 1998-11
- Primary completion
- 1998-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ESR 1150 CL | Unknown | 0.015 mg | Oral |
| Subject | ESR 1150 CL | Unknown | 1 mg | Oral |
Indications
No indication recorded.